In Brief: Reheis Inc.
This article was originally published in The Tan Sheet
Executive Summary
Reheis Inc.: Introduces private-label antacid products as equivalents to J&J/Merck's Mylanta and Maalox at the Private Label Manufacturers Association trade show Nov. 12-15 in Chicago. The Berkeley Heights, N.J.-based company maintained that with the exception of Mylanta, the Reheis store brand antacids are the only antacids to be pasteurized to eliminate microbial contamination. Available in 12 oz. bottles, the single- and extra-strength versions are expected to be sold at average retail prices of $1.99 and $2.99. The company plans to begin shipping Feb. 1...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning